2lkt
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
==Solution structure of N-terminal domain of human TIG3 in 2 M UREA== | ==Solution structure of N-terminal domain of human TIG3 in 2 M UREA== | ||
| - | <StructureSection load='2lkt' size='340' side='right' caption='[[2lkt]], [[NMR_Ensembles_of_Models | 20 NMR models]]' scene=''> | + | <StructureSection load='2lkt' size='340' side='right'caption='[[2lkt]], [[NMR_Ensembles_of_Models | 20 NMR models]]' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[2lkt]] is a 1 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[2lkt]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Human Human]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2LKT OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2LKT FirstGlance]. <br> |
| - | </td></tr><tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">TIG3 ([ | + | </td></tr><tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">TIG3 ([https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr> |
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2lkt FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2lkt OCA], [https://pdbe.org/2lkt PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2lkt RCSB], [https://www.ebi.ac.uk/pdbsum/2lkt PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2lkt ProSAT]</span></td></tr> |
</table> | </table> | ||
== Function == | == Function == | ||
| - | [[ | + | [[https://www.uniprot.org/uniprot/HRSL4_HUMAN HRSL4_HUMAN]] Exhibits PLA1/2 activity, catalyzing the calcium-independent hydrolysis of acyl groups in various phosphotidylcholines (PC) and phosphatidylethanolamine (PE). For most substrates, PLA1 activity is much higher than PLA2 activity. N- and O-acylation activity is hardly detectable.<ref>PMID:19615464</ref> |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 23: | Line 23: | ||
</StructureSection> | </StructureSection> | ||
[[Category: Human]] | [[Category: Human]] | ||
| + | [[Category: Large Structures]] | ||
[[Category: Wang, L]] | [[Category: Wang, L]] | ||
[[Category: Xia, B]] | [[Category: Xia, B]] | ||
Revision as of 10:12, 12 May 2021
Solution structure of N-terminal domain of human TIG3 in 2 M UREA
| |||||||||||
Categories: Human | Large Structures | Wang, L | Xia, B | Yu, W | Human tumor suppressor ii family | Hydrolase | Nlpc/p60 | Tig3
